Andrea Baccarelli1, Sanjukta Ghosh. 1. Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA. abaccare@hsph.harvard.edu
Abstract
PURPOSE OF REVIEW: Epigenetic modifications are heritable alterations of the genome, which can govern gene expression without altering the DNA sequence. The purpose of this review is to render an overview of the possible mechanisms of epigenetic regulation of gene expression in response to environmental pollutants leading to cardiovascular diseases (CVD). RECENT FINDINGS: An era of cataloging epigenetic marks of the various diseased states has recently commenced, including those within the genes responsible for atherosclerosis, ischemia, hypertension and heart failure. From varied study approaches directed either toward the general understanding of the key pathway regulatory genes, or sampling population cohorts for global and gene-specific changes, it has been possible to identify several epigenetic signatures of environmental exposure relevant to CVD. Signatures of epigenetic dysregulation can be detected in peripheral blood samples, even within a few hours of environmental exposure. However, the field now faces the demand for thorough, systematic, rationalized approaches to establish the relation of exposure-driven epigenetic changes to clinical outcomes, by using sophisticated and reliable research designs and tools. SUMMARY: An understanding of chromatin remodelling in response to environmental stimuli conducive to CVD is emerging, with the promise of novel diagnostic and therapeutic candidates.
PURPOSE OF REVIEW: Epigenetic modifications are heritable alterations of the genome, which can govern gene expression without altering the DNA sequence. The purpose of this review is to render an overview of the possible mechanisms of epigenetic regulation of gene expression in response to environmental pollutants leading to cardiovascular diseases (CVD). RECENT FINDINGS: An era of cataloging epigenetic marks of the various diseased states has recently commenced, including those within the genes responsible for atherosclerosis, ischemia, hypertension and heart failure. From varied study approaches directed either toward the general understanding of the key pathway regulatory genes, or sampling population cohorts for global and gene-specific changes, it has been possible to identify several epigenetic signatures of environmental exposure relevant to CVD. Signatures of epigenetic dysregulation can be detected in peripheral blood samples, even within a few hours of environmental exposure. However, the field now faces the demand for thorough, systematic, rationalized approaches to establish the relation of exposure-driven epigenetic changes to clinical outcomes, by using sophisticated and reliable research designs and tools. SUMMARY: An understanding of chromatin remodelling in response to environmental stimuli conducive to CVD is emerging, with the promise of novel diagnostic and therapeutic candidates.
Authors: Kaare Harald Bønaa; Inger Njølstad; Per Magne Ueland; Henrik Schirmer; Aage Tverdal; Terje Steigen; Harald Wang; Jan Erik Nordrehaug; Egil Arnesen; Knut Rasmussen Journal: N Engl J Med Date: 2006-03-12 Impact factor: 91.245
Authors: Rita Castro; Isabel Rivera; Eduard A Struys; Erwin E W Jansen; Paula Ravasco; Maria Ermelinda Camilo; Henk J Blom; Cornelis Jakobs; Isabel Tavares de Almeida Journal: Clin Chem Date: 2003-08 Impact factor: 8.327
Authors: Ann Zenobia Moore; Dena G Hernandez; Toshiko Tanaka; Luke C Pilling; Mike A Nalls; Stefania Bandinelli; Andrew B Singleton; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2015-09-09 Impact factor: 6.053
Authors: Ali Reza Saadatmand; Viviana Sramek; Silvio Weber; Daniel Finke; Matthias Dewenter; Carsten Sticht; Norbert Gretz; Till Wüstemann; Marco Hagenmueller; Stephan R Kuenzel; Stefanie Meyer-Roxlau; Martin Kramer; Samuel Sossalla; Lorenz H Lehmann; Susanne Kämmerer; Johannes Backs; Ali El-Armouche Journal: Proc Natl Acad Sci U S A Date: 2019-10-16 Impact factor: 11.205
Authors: Ting Wang; Erica C Pehrsson; Deepak Purushotham; Daofeng Li; Xiaoyu Zhuo; Bo Zhang; Heather A Lawson; Michael A Province; Christopher Krapp; Yemin Lan; Cristian Coarfa; Tiffany A Katz; Wan Yee Tang; Zhibin Wang; Shyam Biswal; Sanjay Rajagopalan; Justin A Colacino; Zing Tsung-Yeh Tsai; Maureen A Sartor; Kari Neier; Dana C Dolinoy; Jayant Pinto; Robert B Hamanaka; Gokhan M Mutlu; Heather B Patisaul; David L Aylor; Gregory E Crawford; Tim Wiltshire; Lisa H Chadwick; Christopher G Duncan; Amanda E Garton; Kimberly A McAllister; Marisa S Bartolomei; Cheryl L Walker; Frederick L Tyson Journal: Nat Biotechnol Date: 2018-03-06 Impact factor: 54.908